Theleme Partners LLP

13F Portfolio Filings

Most recent 13F
Q4 2023
Location
London, United Kingdom
CIK
0001511881
All SEC filings
View on sec.gov
Holdings Value
Quarter Holdings Value ($000) Top Holdings Form Type Date Filed Filing ID
Q4 2023 10 2,096,908 MRNA, SCHW, WFC, MRNA calls 13F-HR 2/13/2024 000091957424000888
Q3 2023 10 1,991,301 MRNA, SCHW, WFC, QCOM 13F-HR 11/13/2023 000091957423006214
Q2 2023 9 2,209,371 MRNA, WFC, SCHW, URI 13F-HR 8/14/2023 000091957423004617
Q1 2023 11 2,325,443 MRNA, WFC, SCHW, AA 13F-HR 5/15/2023 000091957423003118
Q4 2022 11 2,651,641 MRNA, WFC, SCHW, AA 13F-HR 2/10/2023 000091957423000903
Q3 2022 10 2,050,501 MRNA, WFC, SCHW, META 13F-HR 11/14/2022 000091957422006674
Q2 2022 12 2,495,526 MRNA, WFC, LRCX, META 13F-HR 8/12/2022 000091957422004750
Q1 2022 11 3,130,870 MRNA, WFC, AA, LRCX 13F-HR 5/13/2022 000091957422003165
Q4 2021 10 5,982,146 IWM puts, MRNA, WFC, AA RESTATEMENT 5/26/2022 000091957422003643
Q3 2021 7 3,503,184 MRNA, WFC, META, AA RESTATEMENT 5/26/2022 000091957422003642
Q2 2021 9 3,424,992 MRNA, WFC, TMUS, ADI 13F-HR 8/13/2021 000091957421005075
Q1 2021 12 2,988,347 MRNA, WFC, TMUS, AZO 13F-HR 5/13/2021 000091957421003381
Q4 2020 16 3,045,654 WFC, MRNA, TMUS, CARR 13F-HR 2/12/2021 000091957421000996
Q3 2020 16 2,176,111 MRNA, WFC, URI, VMC 13F-HR 11/13/2020 000091957420006890
Q2 2020 15 2,119,295 MRNA, WFC, URI, WFC calls 13F-HR 8/14/2020 000091957420005173
Q1 2020 14 1,389,889 WFC, MRNA, URI, WFC calls 13F-HR 5/15/2020 000091957420003386
Q4 2019 7 1,775,359 WFC, BAC, URI, AXP 13F-HR 2/13/2020 000091957420000982
Q3 2019 11 2,161,310 WFC, BAC, WFC calls, URI 13F-HR 11/13/2019 000091957419006880
Q2 2019 10 2,061,371 WFC, BAC, WFC calls, SCHW 13F-HR 8/14/2019 000091957419005208
Q1 2019 8 1,674,905 BAC, WFC, SCHW, RTX 13F-HR 5/15/2019 000091957419003687
Q4 2018 10 1,977,651 WFC, SCHW, BAC, WFC calls 13F-HR 2/14/2019 000091957419001251
Q3 2018 7 1,825,600 WFC, SCHW, BAC, RTX 13F-HR 11/13/2018 000091957418007123
Q2 2018 8 1,930,689 SCHW, WFC, BAC, BAC+A 13F-HR 8/13/2018 000091957418005296
Q1 2018 7 1,990,838 SCHW, WFC, BAC, BAC+A 13F-HR 5/14/2018 000091957418003466
Q4 2017 7 2,133,084 SCHW, WFC, BAC, BAC+A 13F-HR 2/14/2018 000091957418001604
Q3 2017 8 1,933,438 BAC, SCHW, WFC, BAC+A 13F-HR 11/13/2017 000091957417007722
Q2 2017 7 1,873,177 SCHW, BAC, WFC, BAC+A 13F-HR 8/11/2017 000091957417005892
Q1 2017 7 1,873,469 SCHW, BAC, WFC, SPGI 13F-HR 5/12/2017 000091957417003958
Q4 2016 7 1,772,192 SCHW, BAC, WFC, SPGI 13F-HR 2/13/2017 000091957417001262
Q3 2016 6 1,387,656 SCHW, BAC, WFC, SPGI 13F-HR 11/14/2016 000091957416016584
Q2 2016 7 1,330,753 WFC, SCHW, BAC, VMC 13F-HR 8/12/2016 000091957416014557
Q1 2016 8 1,490,195 WFC, SCHW, BAC, VMC 13F-HR 5/13/2016 000091957416012862
Q4 2015 9 1,527,992 WFC, SCHW, BAC, VMC 13F-HR 2/12/2016 000091957416010208
Q3 2015 9 1,422,266 WFC, SCHW, BAC, VMC 13F-HR 11/13/2015 000091957415007823
Q2 2015 9 1,565,866 WFC, SCHW, BAC, SPGI 13F-HR 8/13/2015 000091957415005875
Q1 2015 9 1,490,320 WFC, SCHW, BAC, SPGI 13F-HR 5/14/2015 000091957415003990
Q4 2014 8 1,670,900 WFC, SCHW, BAC, MHK 13F-HR 2/13/2015 000091957415001428
Q3 2014 8 1,507,732 WFC, SCHW, BAC, SPGI 13F-HR 11/13/2014 000091957414006196
Q2 2014 10 1,504,632 WFC, SCHW, BAC, SPGI 13F-HR 8/13/2014 000091957414004351
Q1 2014 12 1,533,246 WFC, SCHW, BAC, SPGI 13F-HR 5/14/2014 000091957414002934
Q4 2013 14 1,687,140 WFC, SCHW, AXP, BAC 13F-HR 2/13/2014 000091957414000871
Additional filings from Theleme Partners LLP that have since been restated